AAPP Scientific Poster Session Abstracts

A Cross-Sectional Assessment of Perinatal Mental Health of Birthing People Major Depression Maternal Mental Health Postpartum Depression Postpartum Anxiety Barriers To Mental Health Special Populations

A Pharmacodynamic Study Comparing IN Nalmefene to IN Naloxone in Healthy Volunteers Opioid Use Disorder Substance Use Disorders Naloxone Nalmefene Opioid Overdose

A Retrospective Review of Readmission Rates in Patients Initiated on Long-acting Injectable Antipsychotics During Psychiatric Hospitalization Adherence Antipsychotics Bipolar Disorder Long-Acting Injectable Schizophrenia Relapse Remission Readmission Schizoaffective Disorder

A Search and Seizure for Relief- The Effective Pharmacological Treatment of Psychogenic Non-Epileptic Seizures (PNES) with Escitalopram Adherence Antidepressants Major Depression Monitoring Neurology VA Seizures Psychogenic Nonepileptic Seizures

Absolute Neutrophil Count Monitoring in Clozapine Patients with a Point of Care Fingerstick Device: A Quality Improvement Research Project Antipsychotics Monitoring Schizophrenia Clozapine POCT

Acting on the AUDIT-C: Implementation of Direct-to-Consumer Education on Unhealthy Alcohol Use Alcohol Use Disorder Education/Training/Stigma VA

Addressing the Rising Stimulant Overdose Crisis With Academic Detailing Harm Reduction Stimulants Substance Use Disorders VA Academic Detailing Overdose Stimulant Use Disorder

Agitation in the Emergency Department: Are patients that receive droperidol less likely to require rescue medications versus those that receive olanzapine Acute Agitation Antipsychotics VA Emergency Department Rescue Medication

Analysis of Impact of COVID-19 Regulations on Mental Health Trends and Prescribing Patterns in an Institutionalized, Older Adult Population Antidepressants Anxiolytics COVID-19 Geriatrics Major Depression

Analysis of Psychiatric Pharmacist Telephone Outreach Interventions Using the Veterans Affairs National Academic Detailing Services Alcohol Use Disorder Dashboard  Alcohol Use Disorder Substance Use Disorders VA Population Health Management

Anticholinergic Ordering for Extrapyramidal Symptom (EPS) Prophylaxis and Incidence of EPS in Patients Treated With Antipsychotics Antipsychotics Extrapyramidal Symptoms Anticholinergic

Antidepressant Medication Adherence in a Community Pharmacy Setting Before and After Onset of the COVID-19 Pandemic Adherence Antidepressants COVID-19

Assessing As-Needed Medication Usage Frequency in Patients with Schizophrenia and Schizoaffective Disorder on Antipsychotic Medications for Acute Agitation Acute Agitation Adherence Antipsychotics Anxiolytics Schizophrenia Therapeutic Drug Monitoring

Assessing Behavioral Health Education and Training Needs of Pharmacy Personnel in Pennsylvania Education/Training/Stigma Suicide Needs Assessment

Assessing the Appropriateness of Antipsychotic Prescribing Practices in Patients with Dementia in an Inpatient Community Living Center Antipsychotics Geriatrics Neurology

Assessing the Efficacy of Battlefield Acupuncture for Reducing Pain Scores in Veterans Prescribed Opioid Therapy Major Depression Opioid Use Disorder Post-Traumatic Stress Disorder/ PTSD VA Pain

Assessing the Impact of Culture and Stigma on the Utilization of Mental Health Resources Amongst Health Professions Education/Training/Stigma Cultural Stigma Emotional Distress Burnout

Assessing Underutilization of Mental Health Resources at an HBCU Education/Training/Stigma Health Equity Mental Health Student Health Resources HBCU

Assessment of an Integrated Psychiatric Pharmacy Practice within a Rural Internal Medicine Clinic Adherence Alcohol Use Disorder Antidepressants Antipsychotics Anxiolytics Bipolar Disorder Drug-Drug Interactions Major Depression Post-Traumatic Stress Disorder/ PTSD Schizophrenia Sleep Disorder Stimulants Suicide Therapeutic Drug Monitoring Transitions Of Care Mood Stabilizers

Assessment of Buprenorphine Prescribing Practices Overtime Harm Reduction Opioid Use Disorder Substance Use Disorders VA

Assessment of naloxone prescribing patterns before and after the introduction of South Carolina law requiring naloxone to be offered to patients at increased risk of opioid overdose Education/Training/Stigma Harm Reduction Opioid Use Disorder Substance Use Disorders Transitions Of Care Legislation

Association Between Suicide Attempt and Substance Use Education/Training/Stigma Harm Reduction Opioid Use Disorder Stimulants Substance Use Disorders Suicide

Atypical Extrapyramidal Reaction to Haloperidol in a Young Hispanic Male Acute Agitation Antipsychotics Bipolar Disorder Pharmacogenomics

Augmentation With Antipsychotics In Child And Adolescent Patients With Major Depressive Disorder: A Retrospective Analysis Of Prescribing Patterns Antidepressants Antipsychotics Child And Adolescent Psychiatry Major Depression

Buprenorphine Initiation: Is opioid withdrawal necessary? Opioid Use Disorder Substance Use Disorders

Buprenorphine Microdosing in Inpatients with Acute Infectious Illness: A Retrospective Cohort Study Opioid Use Disorder Buprenorphine

Cardiovascular Safety of Amphetamine/ Dextroamphetamine Versus Methylphenidate in Older Adults Geriatrics Stimulants Cardiovascular

Centering Rural Veterans’ Experiences of SUD Care from Clinical Pharmacy Practitioners in VA: Patient Voices as an Implementation Metric Alcohol Use Disorder Opioid Use Disorder Substance Use Disorders VA Patient Experience

Changes in Metabolic Parameters Associated With Lumateperone in Late-Phase Clinical Trials for the Treatment of Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder Antipsychotics Bipolar Disorder Lumateperone

Characterization of Viloxazine’s Serotonergic Effects at Doses Relevant for ADHD Treatment Nonstimulants ADHD Neuroscience

Clinical and Financial Outcomes of a Pharmacist Medication Management Program in an Outpatient Neurologic and Psychiatric Health Care Center Drug-Drug Interactions Monitoring Neurology Medication Therapy Management

Clinical Conundrums of Clozapine on Consult Liaison Psychiatry Antipsychotics Monitoring Adverse Events Clozapine

Clinical Implications of High-Dose Benzodiazepine Use in Veterans Prescribed Ketamine or Esketamine for Treatment-Resistant Depression or Suicidal Ideation. Drug-Drug Interactions Major Depression Suicide Ketamine Benzodiazepine

Clinical Pharmacist Intervention to Ensure Safe Stimulant Prescribing Practices at a Veterans Affairs Facility Adherence Drug-Drug Interactions Harm Reduction Monitoring Stimulants

Clinical Pharmacy Impact in Mental Health Intensive Case Management Antipsychotics Long-Acting Injectable Monitoring Schizophrenia VA

Clozapine and Respiratory Depression: A Case Report Acute Agitation Antipsychotics Drug-Drug Interactions Education/Training/Stigma Harm Reduction Monitoring Schizophrenia Substance Use Disorders Therapeutic Drug Monitoring Transitions Of Care

Clozapine and Risk of Hematologic Malignancies in Veterans with Schizophrenia Antipsychotics Schizophrenia VA Malignancy Clozapine

Clozapine in Black Patients with Tardive Dyskinesia: Results of a 24 Week Open Label Clinical Trial Antipsychotics Schizophrenia Tardive Dyskinesia

Comparing the Efficacy of Incorporating Intramuscular Midazolam or Lorazepam, or no Benzodiazepine, in Combination with Haloperidol and Diphenhydramine for the Treatment of Acute Agitation Acute Agitation Antipsychotics Anxiolytics Emergency Medicine

Comparing the Pharmacokinetics, Efficacy, Tolerability, and Accessibility of Viloxazine versus Atomoxetine Child And Adolescent Psychiatry Drug-Drug Interactions Stimulants ADHD

Comparison of Long-acting Injectable Antipsychotics with Oral Antipsychotics and Hospital Readmission Rates at 3 Months in Pediatric Patients Antipsychotics Bipolar Disorder Child And Adolescent Psychiatry Long-Acting Injectable Schizophrenia

Comparison of Propofol and Methohexital as Anesthetic Agents for Electroconvulsive Therapy Major Depression Electroconvulsive Therapy

Comparison of Safety, Efficacy, and Appropriateness of Dalfampridine Therapy Pre and Post PharmD Intervention: A Retrospective Chart Review Neurology VA Mood Stabilizers MS/ Multiple Sclerosis

Comparison of Weight-Based Valproic Acid Dosing in Treatment of Mental Illness Among Obese and Non-Obese Patients Therapeutic Drug Monitoring Mood Stabilizers Pharmacokinetics Obesity

Comprehensive Chart Evaluations by a Psychiatric Pharmacist in a Community Living Center to Improve Patient Safety Outcomes Geriatrics Harm Reduction VA Polypharmacy

Cost-Avoidance Analysis of Clinical Pharmacist Interventions on Antipsychotic Therapy in Acute Care Psychiatry in an Indigent Minority Population Antipsychotics Health Equity Cost-Avoidance Clinical Pharmacist Intervention

Cost-Effective Analysis Between Valbenazine and Deutetrabenazine in a Veteran Population Antipsychotics Neurology Tardive Dyskinesia

Cross-Mapping the Outpatient Best Practice Model Statements with BCPP and CMM Components Education/Training/Stigma Best Practice Comprehensive Medication Management

Crushing Valbenazine Capsule Contents for Potential Addition to Soft Foods or Administration Via G Tube Stimulants Tardive Dyskinesia

Determining Actionable Veterans for Completion of Pharmacogenomic Testing to Guide Medication Therapy for Post-Traumatic Stress Disorder Antidepressants Monitoring Pharmacogenomics Post-Traumatic Stress Disorder/ PTSD

Developing Ambulatory Care Clinical Pharmacy Services in a Gender Health Program Education/Training/Stigma Transgender Gender Health

Developing Site-Specific Guidelines for Gender-Affirming Care at a Forensic Psychiatric Hospital Education/Training/Stigma Health Equity Forensic Transgender Care

Development of the Core Outcome Set for Psychiatric Pharmacists Psychiatric Pharmacy Practice Psychiatric Pharmacy Advocacy

Don’t be Rash: Risk of cutaneous reactions from rapid retitration of lamotrigine Adherence Bipolar Disorder Neurology Mood Stabilizers

Effect of Direct-to-Consumer Education Plus Pharmacist Outreach on Benzodiazepine Prescribing in Veterans with Posttraumatic Stress Disorder Post-Traumatic Stress Disorder/ PTSD VA Benzodiazepine Deprescribing Direct-To-Consumer

Effectiveness of Group Battlefield Acupuncture to Reduce Pharmacologic Pain Medication Utilization VA Battlefield Acupuncture Pain Management

Effectiveness of Mood Stabilizers Versus Second-Generation Antipsychotics for Pediatric Bipolar Disorder Bipolar Disorder Child And Adolescent Psychiatry

Effects Of A Psychiatric PharmD Rotation On Mental Health Knowledge And Attitudes Towards The Provision Of Pharmaceutical Care To People With Mental Illness Education/Training/Stigma Mood Stabilizers Experiential Education

Efficacy and Safety Comparison of Weekly/monthly Extended-release Injectable Buprenorphine (CAM2038) vs Daily Sublingual Buprenorphine/naloxone (BPN/NX) for Treatment of Patients with OUD Who Inject Opioids or Use Heroin. Harm Reduction Long-Acting Injectable Opioid Use Disorder Substance Use Disorders Buprenorphine

Efficacy and Safety of Iloperidone in Acute and Mixed Mania Associated with Bipolar I Disorder: A Double-Blind, Placebo-Controlled, Phase III Study Antipsychotics Bipolar Disorder Schizophrenia Iloperidone

Efficacy and Safety of Zuranolone in Adults With Major Depressive Disorder With and Without Use of Standard-of-Care Antidepressants at Baseline in the LANDSCAPE Clinical Development Program Antidepressants Major Depression

Efficacy of Long-Acting Injectable Antipsychotics versus Oral Antipsychotics in Preventing Psychiatric Rehospitalizations Antipsychotics Schizophrenia

Esketamine Nasal Spray Versus Quetiapine Extended Release in Patients With Treatment-Resistant Depression: A Subgroup Analysis of the ESCAPE-TRD Study Antidepressants Major Depression Esketamine Treatment-Resistant Depression Psychopharmacology

Establishing a Collaborative Practice Agreement with Prescriptive Authority in a Local Mental Health Authority (LMHA) Collaborative Practice Agreement Innovative Practice Local Mental Health Authority

Evaluating a Novel Pharmacist-Led Buprenorphine Outreach Service for Treatment of Opioid Use Disorder in Individuals Residing in Supportive Housing Harm Reduction Health Equity Opioid Use Disorder Substance Use Disorders

Evaluating Outcomes of the Miami Veteran’s Affairs Healthcare System Syringe Service Program Harm Reduction Substance Use Disorders VA

Evaluating Provider Perception on the Role of Naloxone Use in Veterans with Stimulant Use Disorder (StimUD) Harm Reduction Stimulants Substance Use Disorders VA

Evaluating the Impact of COVID-19 Hospitalization on New-Onset Depression, Dementia, and Healthcare Utilization in a Nationwide Veterans Health Administration Observational Cohort Study Antidepressants COVID-19 Geriatrics Major Depression VA

Evaluating the Impact of Photovoice on Self-Stigma Levels Among Individuals with Substance Use Concerns Alcohol Use Disorder Education/Training/Stigma Opioid Use Disorder Substance Use Disorders Self-Stigma Photovoice Public Stigma

Evaluating the Impact of Psychiatric Pharmacists in a Developmental Disabilities Clinic Developmental Disorders

Evaluating the Usefulness of Culturally-Sensitive Mental Health Resources for PharmD Students and Graduate Students Education/Training/Stigma Diversity Equity And Inclusion (DEI)

Evaluation of Antipsychotic Monitoring in a Community Health Center during the COVID-19 Pandemic Antipsychotics Monitoring Therapeutic Drug Monitoring Metabolic Monitoring Movement Disorders

Evaluation of Appropriate Lithium Monitoring in a Hospital System Adherence Bipolar Disorder Education/Training/Stigma Major Depression VA Mood Stabilizers

Evaluation of Changes in Clozapine Prescribing Patterns Among Providers at VAPORHCS Following Expansion of Prescribing Privileges within VA Practice Antipsychotics Bipolar Disorder Schizophrenia VA

Evaluation of Major Adverse Events and Drug Discontinuation of Clozapine Based on Accordance to an International Adult Titration Guideline Antipsychotics Drug-Drug Interactions Monitoring Schizophrenia Therapeutic Drug Monitoring Clozapine Drug Related Side Effects And Adverse Reactions Inflammation Ancestry Titrations

Evaluation of Medicaid Prescriber Report Card Intervention to Promote Appropriate Prescribing and Monitoring of Antipsychotics to Philadelphia’s Youths. Antipsychotics Child And Adolescent Psychiatry Monitoring Quality Improvement Evaluation

Evaluation of Medications for Opioid Use Disorder Utilization During Medical Inpatient Hospitalization Education/Training/Stigma Opioid Use Disorder Substance Use Disorders Transitions Of Care

Evaluation of Rehospitalization Rates for Alcohol Use Disorder Management in the Inpatient Veteran Setting Based on Alcohol Use Disorder Medication Initiation Alcohol Use Disorder VA

Evaluation of the Impact of a Mental Health Pharmacist in the Care of Veterans with Early Psychosis Antipsychotics Monitoring Schizophrenia

Evaluation of Veterans on Buprenorphine-based Products for Opioid Use Disorder Who are Stable for Step-Down Treatment from Specialty Care Opioid Use Disorder Substance Use Disorders VA

Examining Mental Health Effects of Hormonal Contraceptives in Women Veterans Antidepressants Anxiolytics Major Depression Monitoring VA Women's Health

Examining The Clinical Utility Of Pharmacist-Led Service Reviewing Aberrant Urine Drug Screens Harm Reduction Monitoring

Examining the Efficacy and Safety of Intravenous Ketamine vs. Intranasal Esketamine for Treatment Resistant Depression Bipolar Disorder Major Depression

Expanding Access to Pre-Exposure Prophylaxis (PrEP) to Veterans Who Inject Drugs Harm Reduction Substance Use Disorders IV Drug Use PrEP

Exploring the Impact of a Psychiatric Pharmacist in Resolving Drug Therapy Problems and Improving Patient Outcomes at a Mental Health Center Antidepressants Antipsychotics Bipolar Disorder Major Depression Schizophrenia Therapeutic Drug Monitoring Drug Therapy Problems Comprehensive Medication Management Medication Therapy Problems CGI-I Patient Outcomes

Exploring the Influence of Psychosocial Interventions on Cancer Treatment Outcomes in Patients with Co-morbid Mental Health Conditions Psycho-Oncology

Factors Affecting Treatment Retention for Long-Acting Injectable Antipsychotics Antipsychotics Long-Acting Injectable Treatment Retention

Gender Health Client Perceptions of Clinical Psychiatric Pharmacist Interactions: A Convergent Parallel Mixed Method Study Health Equity Suicide Transitions Of Care Gender Dysphoria Gender Health

Historical Use of Phenobarbital for Alcohol Withdrawal Syndrome at an Academic Medical Center Alcohol Use Disorder Anxiolytics Substance Use Disorders Alcohol Withdrawal

Identifying Predictors of Adherence to Long-acting Naltrexone Injection Following Discharge from an Acute Inpatient Psychiatric Unit Adherence Alcohol Use Disorder Long-Acting Injectable VA

Impact Of A Community Immersion Experience On Student Pharmacists' Associated Stigma Of Serious Mental Illness Education/Training/Stigma Serious/severe Psychiatric/mental Disorder/ Illness Mental Health Stigma Community Immersion Experience

Impact of a Pharmacist-driven Tardive Dyskinesia Education Service on Adherence to Recommended AIMS Monitoring Antipsychotics Monitoring VA

Impact of an Alcohol Use Disorder Order Set in the Emergency Department on Veteran Care and Health Outcomes Alcohol Use Disorder Substance Use Disorders VA Alcohol Withdrawal Emergency Department

Impact of Antipsychotic-Induced Weight Gain on Discontinuation of Oral Second-Generation Antipsychotics at a Veterans Hospital Adherence Antipsychotics Monitoring VA

Impact of Depression Support Text Message Intervention Adherence Antidepressants Major Depression Suicide

Impact of Early Peer Specialist Involvement on Medication Assisted Treatment Engagement and Treatment Retention in Patients with Substance Use Disorders Adherence Alcohol Use Disorder Education/Training/Stigma Harm Reduction Opioid Use Disorder Substance Use Disorders Transitions Of Care MAT Peer Specialists

Impact of mental health clinical pharmacist practitioner services within a Veterans Affairs Clinical Resource Hub VA Telehealth

Impact of Mental Health Clinical Pharmacy Practitioners Providing Measurement Based Care through Clinical Resource Hub Major Depression Monitoring VA Measurement Based Care Telemedicine

Impact of Participation in an Adolescent Medication Group on Pharmacy Intern Implementation and Knowledge of Psychotropic Medications and Patient Outcomes Adherence Antidepressants Antipsychotics Anxiolytics Bipolar Disorder Child And Adolescent Psychiatry Drug-Drug Interactions Education/Training/Stigma Major Depression Monitoring Post-Traumatic Stress Disorder/ PTSD Schizophrenia Sleep Disorder Stimulants Substance Use Disorders Suicide Transitions Of Care Mood Stabilizers

Impact of Patient Support Programs on Clozapine Persistence and Cost: A Canadian Perspective Antipsychotics Schizophrenia Therapeutic Drug Monitoring Drug Pricing

Impact of Therapeutic Drug Level Monitoring of Antipsychotics in Treatment Management at an Inpatient Psychiatric Hospital Antipsychotics Monitoring Therapeutic Drug Monitoring

Impact of Triptan and CGRP Receptor Antagonist Utilization on Plan Management for an Employer-Sponsored Health Plan for a Large Academic Medical Center Neurology Migraine Managed Care Triptans Calcitonin Gene-Related Peptide Receptor Antagonists Drug Utilization

Implementation and Analysis of Harm Reduction Education Groups for Behavioral Health Patients   Education/Training/Stigma Harm Reduction Substance Use Disorders

Implementation and Evaluation of PHASER Pharmacogenetic Testing Program in a Veterans Affairs Mental Health Setting Antidepressants Antipsychotics Anxiolytics Major Depression Monitoring Pharmacogenomics VA PHASER CPIC

Implementation and Outcomes of a Behavioral Health Integration Program: A Focus on Post-discharge Follow-up and Transitions of Care Adherence Education/Training/Stigma Health Equity Monitoring Transitions Of Care

Implementation of a Harm Reduction Program at the West Palm Beach VA Health Care System Education/Training/Stigma Harm Reduction Opioid Use Disorder Substance Use Disorders

Implementation of a MAT Program in a County Jail Antidepressants Harm Reduction Opioid Use Disorder Substance Use Disorders

Implementation of a Multiple Antipsychotic Pharmacy Consult at a Veterans Affairs Health Care System Antipsychotics Schizophrenia VA

Implementation of a Pharmacist-Driven Antipsychotic Taper Protocol for Acute Agitation and/or Delirious Hospitalized Patients Acute Agitation Antipsychotics Harm Reduction Transitions Of Care Delirium

Implementation of a pharmacist-led suicide and overdose risk mitigation clinic at a VA Medical Center Education/Training/Stigma Harm Reduction Suicide

Implementation of a Virtual Interprofessional Geriatric Mental Health Service Geriatrics VA Interprofesisonal Virtual Care Modalities

Implementation of an Ambulatory Alcohol Detoxification Clinic at a Veterans Affairs Medical Center Alcohol Use Disorder Monitoring Substance Use Disorders VA

Implementation of harm reduction services at a Veteran's Affairs (VA) facility Harm Reduction VA

Implementation of Psychiatric Pharmacists at Academic Medical Center Education/Training/Stigma Transitions Of Care Emergency Department Consult Liaison Psychiatry

Implementing Naloxone Kit Distribution in a Veterans Affairs Hospital Emergency Department Education/Training/Stigma Harm Reduction VA

Implementing Standardized Ketamine Dosing for Treatment Resistant Depression Major Depression Ketamine

Implications of Clozapine Monitoring During the COVID-19 Pandemic Antipsychotics COVID-19 Monitoring Schizophrenia VA

Improvements in Cognitive and Physical Functioning Outcomes in Depressed Patients Treated with AXS-05 (Dextromethorphan-Bupropion): Results from the EVOLVE Open-Label, Long-Term Study Antidepressants Major Depression

Improving Hemoglobin A1c Monitoring of Veterans on Second-Generation Antipsychotics through Implementation of an Expanded Ordering Template Antipsychotics Bipolar Disorder Long-Acting Injectable Monitoring Schizophrenia VA Metabolic Monitoring Hemoglobin A1c Metabolic Sydrome

Improving Management of Opioid Withdrawal Symptoms on an Inpatient Psychiatry Unit at Salem Veterans Affairs Health Care System Monitoring Opioid Use Disorder VA

Incidence of Anti-hypertensive Therapy Initiation in Patients Taking Serotonin and Norepinephrine Reuptake Inhibitors: An Evaluation of Prescribing Cascades at Gundersen Health System Antidepressants Anxiolytics Prescribing Cascades

Increasing Naloxone Prescription Rates in a Veteran Population with Stimulant Use Disorder Through Combination Pharmacist Outreach and Education to Mental Health Professionals Harm Reduction Stimulants Substance Use Disorders VA Overdose Prevention Opioid Stimulant Use Disorder

Increasing the Dispensing of Naloxone to At-Risk Patients in the Emergency Department Opioid Use Disorder Substance Use Disorders

Inflammation with Intolerance after Early Clozapine Exposure: A Rationale for Early CRP Monitoring Beyond Myocarditis Antipsychotics Bipolar Disorder Therapeutic Drug Monitoring Clozapine

Interim Analysis of Efficacy During Long-Term Treatment with Viloxazine Extended-Release Capsules in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: An Open-Label Extension Study Child And Adolescent Psychiatry ADHD Nonstimulant Pharmacotherapy

Investigation of Changes in Naltrexone Long-Acting Injection Use Due to COVID-19 Pandemic Alcohol Use Disorder COVID-19 Long-Acting Injectable VA

Is a Partial Initiation of Paliperidone Palmitate Effective at Reducing Emergency Psychiatric Encounters? Adherence Antipsychotics Long-Acting Injectable

Is Early Response the More Appropriate Outcome for Depression Studies? Antidepressants Health Equity Major Depression Monitoring

Knowledge of Pharmacists' Role in the Management of Opioid Use Disorder: Pharmacy Students' Perspective Opioid Use Disorder Pharmacists' Role

Lithium Dosing in Post-Transplant Patient with Unstable Fluid-Electrolyte Status: A Case Report Bipolar Disorder Drug-Drug Interactions Harm Reduction Monitoring Therapeutic Drug Monitoring Mood Stabilizers

Long-Term Efficacy of Treatment with Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder: Results from an Open-Label Extension Study ADHD Nonstimulant Pharmacotherapy

Long-Term Lumateperone Treatment in Bipolar Disorder: Six-Month Open-label Extension Study Antipsychotics Bipolar Disorder Lumateperone

Long-term Retrospective Study of Weight Change in Cannabis Positive Outpatients with Schizophrenia or Bipolar 1 Disorder receiving treatment with Olanzapine/samidorphan vs Olanzapine Alone. Antipsychotics Bipolar Disorder Schizophrenia Substance Use Disorders Mood Stabilizers Cannabis

Long-Term Safety and Symptom Trajectory With Aripiprazole Lauroxil in Female Patients With Schizophrenia: A Post Hoc Subgroup Analysis Antipsychotics Schizophrenia Long-Term Safety Females PANSS

Lumateperone in the Treatment of Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: Evaluation of Extrapyramidal and Motor Symptoms in Late-Phase Clinical Trials Antipsychotics Bipolar Disorder Lumateperone

Medical Cannabis in the Treatment of Parkinson’s Disease Neurology Medical Cannabis Parkinson's Disease

Medication Utilization for Managing Agitated Patients Based on Implicit Bias Acute Agitation Antipsychotics Health Equity

Methodology for Evaluating the REMS Programs for Psychiatric Medications Monitoring REMS Research Methodology

Myoclonic Jerks Following Clozapine Initiation Antipsychotics Monitoring Schizophrenia Clozapine Seizures

Naloxone Co-Prescribing Practices for High-Risk Patients in an Academic Medical Center Family Medicine Clinic Harm Reduction Opioid Use Disorder Substance Use Disorders Transitions Of Care

Naloxone Prescribing and Clinical Pharmacy Specialist Interventions at the Cincinnati Veterans Affairs Medical Center (CVAMC) Geriatrics Harm Reduction Opioid Use Disorder Substance Use Disorders Suicide

Neuroleptic Malignancy Syndrome? Benzodiazepine Withdrawal? Both?: A Case Report Acute Agitation Antipsychotics Substance Use Disorders Neuroleptic Malignant Syndrome (NMS)

Newer Antiseizure Medications and Suicidality: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) Database Antipsychotics Harm Reduction Monitoring Neurology Suicide Therapeutic Drug Monitoring

Nudging Behavioral Changes: Evidence from Healthy Eating Challenge Behavioral Change Nutrition Goal Setting Self Reflection Education

Optimizing Antipsychotic Dosing Through a Pharmacy Driven Evidence-Based Titration Schedule: a Retrospective, Prospective, Quality-Improvement Study Antipsychotics Bipolar Disorder Monitoring Schizophrenia

Optimizing Collaboration Among Clinical Pharmacy Specialists and Behavioral Health Providers in The Primary Care Setting Education/Training/Stigma Major Depression Primary Care Anxiety Multidisciplinary

Outreach Visits by Pharmacist Improves Adherence to Long-Acting Injectable Antipsychotics in a Rural Setting Adherence Antipsychotics Long-Acting Injectable Schizophrenia Therapeutic Drug Monitoring Rural Health Outreach Home Visit

Paliperidone Palmitate And Prazosin-Induced Retrograde Ejaculation In A Psychiatrically Stabilized Patient With Bipolar I Disorder Antipsychotics Bipolar Disorder Harm Reduction Long-Acting Injectable Monitoring VA Adverse Reactions

Patient Characteristics Associated with Episodes of Agitation Acute Agitation Education/Training/Stigma Harm Reduction Monitoring Patient Safety Provider Safety Restraint/Seclusion Electronic Medical Record

Patient-Experienced Stigma: Perceptions Regarding Obtaining Prescription Stimulant ADHD Medications Education/Training/Stigma Stimulants ADHD

Pharmacist Impact on Administration Intervals and Appropriate Titration of Long-Acting Injectable Antipsychotics (LAIAs) through Monitoring, Alerts, and Interventions Adherence Antipsychotics Long-Acting Injectable Monitoring VA

Pharmacist Impact on Expanding Naloxone Access and Distribution to Patients with Stimulant Use Disorders via Targeted Secure Messaging Harm Reduction Stimulants Substance Use Disorders Naloxone

Pharmacist Reported Protocols for QTc Monitoring for Psychiatric Medications Antidepressants Antipsychotics QTc Prolongation

Pharmacist-Based Medication Reconciliation for High-Risk Community Patients Adherence Antidepressants Antipsychotics Anxiolytics Bipolar Disorder Harm Reduction Health Equity Long-Acting Injectable Major Depression Monitoring Schizophrenia Substance Use Disorders Suicide Transitions Of Care

Pharmacist-Conducted Comprehensive Psychiatric Medication Reviews of Hospitalized Psychiatric Inpatients Inpatient Medication History

Pharmacist-Led Optimization of Discharge Medication Reconciliation for Long-Acting Injectable Antipsychotics Adherence Antipsychotics Education/Training/Stigma Long-Acting Injectable Schizophrenia

Pharmacists Teaming Up in the University Outpatient Psychiatric Clinic to Effectively Implement Pharmacogenomics Clinical Services Pharmacogenomics Medication Therapy Management

Pharmacogenomic Testing in Veterans with Treatment Resistant Major Depressive Disorder (MDD) Antidepressants Major Depression Pharmacogenomics VA

Pharmacogenomics (PGx) in the Electronic Health Record (EHR) Health Equity Pharmacogenomics Health Informatics

Pharmacotherapy for Pediatric and Adolescent Agitation in an Inpatient Behavioral Health Unit Acute Agitation Child And Adolescent Psychiatry

Picking the Brain: Treatment of Amphetamine/Dextroamphetamine Induced Excoriation Disorder Monitoring Stimulants ADHD Excoriation Disorder Dermatillomania Skin Picking

Piloting an Outpatient Pharmacy Mental Health Consultation Service Monitoring VA Pharmacy Service

Policies and Recommendation Frequencies for Medications for Opioid Use Disorder in Professional Recovery Programs in the U.S. Education/Training/Stigma Opioid Use Disorder Substance Use Disorders

Postictal Agitation After Electroconvulsive Therapy: Risk Factors and Treatment Acute Agitation ECT

Potential Benefit of Naltrexone in a Patient with Autistic Disorder and Borderline Personality Disorder Exhibiting Self Injurious Behaviors Acute Agitation Bipolar Disorder Naltrexone Autism Spectrum Disorder Borderline Personality Disorder Self Injurious Behavior

Preliminary Evaluation of Psychiatric Pharmacist Services in the Outpatient Setting Antidepressants Anxiolytics Major Depression Best Practices Model

Prevalence of and Factors Associated with Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) and Tricyclic Antidepressants (TCAs) Concurrent Prescribing Among Texas Medicaid Adults Antidepressants Drug-Drug Interactions Polypharmacy

Prevalence of Drugs of Abuse Usage in Veterans with ADHD treated with Stimulants vs. Non-Stimulants Harm Reduction Monitoring Stimulants Substance Use Disorders

Protocol for a Multi-Site Study Implementing a Pharmacist-Integrated Collaborative Model of Medication Treatment for Opioid Use Disorder in Primary Care Education/Training/Stigma Harm Reduction Opioid Use Disorder Collaborative Care

Psychotropic Stewardship: Advancing Patient Care Antidepressants Antipsychotics Drug-Drug Interactions Monitoring Therapeutic Drug Monitoring Transitions Of Care Psychotropic Stewardship Psychiatric Pharmacists Comprehensive Medication Management Psychiatric Disorder Psychotropic Drugs

Quality Improvement for Metabolic Monitoring of Children and Adolescents Prescribed an Antipsychotic Antipsychotics Child And Adolescent Psychiatry Harm Reduction Monitoring Side Effects Quality Improvement

Rapid Antidepressant Effects of Zuranolone in Patients With Major Depressive Disorder and Postpartum Depression: Overview of the LANDSCAPE and NEST Clinical Development Programs Major Depression Postpartum Depression

Real World Impact of Patients with Bipolar Disorder or Schizophrenia who Experience High Frequency of Agitation Episodes Acute Agitation Bipolar Disorder Schizophrenia Healthcare Resource Utilization

Real-World Adherence to Deutetrabenazine or Valbenazine Among Patients With Tardive Dyskinesia Adherence Neurology Tardive Dyskinesia Deutetrabenazine Valbenazine

Real-World Effectiveness and Safety of Deutetrabenazine in Combination with Antipsychotic Drugs in Patients With Chorea Associated With Huntington Disease Antipsychotics Neurology Huntington Disease Chorea Deutetrabenazine

Real-World Insights Into Long-Acting Injectable Antipsychotic Agent (LAI) Initiation in the Inpatient Setting and Transition/Continuation-of-Care: Impact of LAI Characteristics on Outcomes Among Patients With Schizophrenia Adherence Antipsychotics Long-Acting Injectable Schizophrenia Transitions Of Care

Retrospective Review of Racial Disparities in Treatment of Agitation in an Academic Medical Center Acute Agitation Antipsychotics Anxiolytics Education/Training/Stigma Harm Reduction Health Equity Major Depression Schizophrenia Racial Disparities Restraints And Seclusion

Review of the TAAR1 Agonist Ulotaront: Part I - from Discovery to Clinic Antipsychotics Schizophrenia TAAR1 Preclinical Discovery

Review of the TAAR1 Agonist Ulotaront: Part II - Summary of Initial Clinical Efficacy/Safety Results Antipsychotics TAAR1 Clinical Trials

Safety and Effectiveness Outcomes of Conversion of Intravenous Ketamine or Intranasal Esketamine to Intramuscular Ketamine Antidepressants Bipolar Disorder Major Depression Post-Traumatic Stress Disorder/ PTSD Suicide VA Ketamine

Safety and Efficacy of KarXT (Xanomeline–Trospium) in Schizophrenia in the Phase 3, Randomized, Double-Blind, Placebo-Controlled EMERGENT-2 Trial Antipsychotics Schizophrenia Muscarinic Receptor Agonist Xanomeline KarXT

Safety of Deutetrabenazine Above Food and Drug Administration Maximum Recommended Dose in Huntington’s Disease Chorea Neurology Huntington's Disease Chorea Chorea Deutetrabenazine Austedo

Self-Stigma of Depression Among Pharmacy Students Education/Training/Stigma Depression

Standardization of Long-acting Injectable Antipsychotic Documentation at a Veterans Affairs Healthcare System Long-Acting Injectable Schizophrenia VA

Subcutaneous Risperidone (TV-46000) Efficacy in Schizophrenia: A Phase 3, Randomized, Double-Blind, Relapse Prevention Study (RISE Study) Antipsychotics Long-Acting Injectable Schizophrenia Long-Acting Subcutaneous Antipsychotic (LASCA)

Subcutaneous Risperidone (TV-46000) Safety and Tolerability in Schizophrenia: A Phase 3, Randomized, Double-Blind, Relapse Prevention Study (RISE Study) Antipsychotics Long-Acting Injectable Schizophrenia Long-Acting Subcutaneous Antipsychotic (LASCA) Safety

Sublingual Dexmedetomidine for the Treatment of Acute Agitation Associated with Schizophrenia or Bipolar Disorder: Effect Size and Pooled Efficacy Acute Agitation Bipolar Disorder Schizophrenia Sublingual Dexmedetomidine

Successful Transition of Patients Referred to a Hospital-Affiliated Long-Acting Therapy Clinic After Inpatient Hospital Stay: A Transitions of Care Analysis Adherence Antipsychotics Bipolar Disorder Long-Acting Injectable Schizophrenia Sleep Disorder Transitions Of Care LAI LAT

Sustained Treatment Response with Long-Term Valbenazine in Patients with Tardive Dyskinesia Tardive Dyskinesia

Systematic Literature Review of the Impact of Psychiatric Pharmacists Adherence Psychiatric Pharmacists Medication-Related Outcomes Patient-Level Outcomes Systematic Literature Review Quadruple Aims

The Development and Implementation of an Intensive Substance Use Disorders Curriculum in a Professional Pharmacy Program Substance Use Disorders Pharmacy Education

The Development and Implementation of Best Practices to Reduce Burnout, Promote Healing, and Revive Inspiration in Psychiatric Clinical Pharmacist Practitioners at a Veteran’s Hospital VA Burnout Workplace

The Effect of Appropriate Utilization of Medications for Opioid Use Disorder (MOUD) on Length of Stay and Readmission in Patients at the Middle Tennessee Mental Health Institute (MTMHI) Opioid Use Disorder Substance Use Disorders

The Impact of Antiseizure Medication on Cardiac Function Bipolar Disorder Neurology Mood Stabilizers Antiseizure Medication

The Impact of Multiple Antipsychotics in Treatment-Resistant Psychosis at a Forensic Psychiatric Hospital Antipsychotics Schizophrenia

The Implementation of Controlled Central Nervous System Stimulant Medical Monitoring Outreach at a Veterans Affairs Hospital Harm Reduction Monitoring Stimulants VA

The Myoclonus Mystery: A Case of Lance-Adams Syndrome Complicated by Withdrawal Seizures of Alcohol Use Disorder Adherence Alcohol Use Disorder Neurology Lance-Adams Syndrome Myoclonus Seizures

The Relationship Between Opioid Overdose Death Rates and Buprenorphine Distribution to Retail Pharmacies in California in 2021 Opioid Use Disorder Substance Use Disorders

There’s no place like home: Clinical Pharmacist Practitioners collaborate with X-waivered providers to provide buprenorphine via home initiations during the COVID-19 pandemic COVID-19 Health Equity Opioid Use Disorder Substance Use Disorders Telehealth

Time-to-Therapy Discontinuation in Patients Newly Diagnosed with Schizophrenia Initiated on Long-Acting Injectable Versus Oral Dopamine Receptor Blocking Agents Adherence Antipsychotics Long-Acting Injectable Schizophrenia

Title: Buprenorphine Enhanced Taper Tolerability Evaluation Report: A Case Report Opioid Use Disorder Substance Use Disorders VA Buprenorphine Taper

Title: Efficacy of Liraglutide in Comparison to Metformin for the Management of Antipsychotic-Induced Weight Gain Antipsychotics Monitoring

Training Pharmacy Students to Administer Long-Acting Injectable Medications Antipsychotics Education/Training/Stigma Long-Acting Injectable

Trazodone versus Doxepin as a Pharmacologic Sleep Aid in Psychiatric Inpatients: A Retrospective Cohort Study Sleep Disorder Trazodone Doxepin Insomnia

Treatment Outcomes of Topiramate in Comorbid Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD) in Veterans Alcohol Use Disorder Post-Traumatic Stress Disorder/ PTSD VA

Tricyclic Antidepressant Serum Concentration Monitoring at an Inpatient Psychiatric Hospital Antidepressants Major Depression Monitoring Therapeutic Drug Monitoring Tricyclic Antidepressants Obsessive–compulsive Disorder

Understanding Adverse Drug Reactions: The Impact of Prescriber and Nurse Education at a State Psychiatric Hospital Education/Training/Stigma Harm Reduction Monitoring Adverse Drug Reaction Quality Improvement

Use of Asenapine in a Patient Concerned About Weight Gain with Olanzapine Adherence Antipsychotics Bipolar Disorder Monitoring

Use of Emergent Intramuscular Diphenhydramine, Haloperidol, and Midazolam in Acute Agitation Management in Patients with Psychiatric Conditions Acute Agitation Midazolam Haloperidol Lorazepam Diphenhydramine

Use of Prazosin, an Alpha-1 Adrenergic Blocker, in Children with PTSD-Associated Nightmares Child And Adolescent Psychiatry Post-Traumatic Stress Disorder/ PTSD Sleep Disorder

Use of Short-Acting Injectable Antipsychotics for Management of Acute Agitation in Adult Inpatient Psychiatry Acute Agitation Antipsychotics

Utility of DEA-Licensed Pharmacist as Primary Prescriber in Benzodiazepine Taper Clinic Anxiolytics Geriatrics Harm Reduction

Utilization and Appropriateness of Single Dose Injectable Aripiprazole Lauroxil in the Treatment of Schizophrenia Adherence Antipsychotics Education/Training/Stigma Long-Acting Injectable Monitoring Schizophrenia Therapeutic Drug Monitoring

Utilization of a State-wide Health Information Exchange for Contingency Management in a Behavioral Health Population Adherence Contingency Management Readmission

Utilization of Extended-Release Buprenorphine Injection to Transition Off of Oral Buprenorphine/Naloxone for Opioid Use Disorder: A Case Series Monitoring Opioid Use Disorder Substance Use Disorders VA Buprenorphine

Utilization of Medication for Opioid Use Disorder in Opioid Treatment Programs Long-Acting Injectable Opioid Use Disorder Substance Use Disorders Transitions Of Care

Validation Of An Algorithm For The Assessment, Management and Monitoring of Drug-induced QTc Prolongation In The Psychiatric Population Drug-Drug Interactions Monitoring Drug-Induced Arrhythimias Algorithm

Words Matter: Analysis of the Language Used When Documenting in the Medical Records of Mental Health Patients Education/Training/Stigma Health Equity Language Documentation Healthcare Providers